Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 103 Dimensions

Readers on

mendeley: 118 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 30,649 followers.

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment. https://t.co/ivQEePRqCY

27 Jun 2018

Reply Repost Favourite

RT @sitcancer: #JITC: Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display mark... https:/…

20 Oct 2017

Reply Repost Favourite

RT @sitcancer: #JITC: Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display mark... https:/…

20 Oct 2017

Reply Repost Favourite

#JITC: Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display mark... https://t.co/4f7DMMR8tP https://t.co/OqT8Fh9rzP

20 Oct 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.